Bausch+Lomb Results Presentation Deck

Reconciliation of Reported Revenue to Organic Revenue ¹,2 and Organic Revenue Growth 1.2 ($M) (Q4 and FY) Bausch + Lomb Vision Care Surgical Ophthalmic Pharmaceuticals Total Bausch + Lomb BAUSCH + LOMB 1. 2. 3. Revenue as Reported 598 172 172 942 Calculation of Organic Revenue for the Three Months Ended September 30, 2022 September 30, 2021 Changes in Exchange Rates ³ 34 13 8 55 Organic Revenue (Non- GAAP) ¹,2 632 185 180 997 Revenue as Reported 605 173 171 949 Divestitures and Discontinuations (1) (1) Organic Revenue (Non- GAAP)¹,2 605 172 171 948 Change in Reported Revenue Amount (7) (1) 1 (7) Pct. -1% -1% 1% -1% Change in Organic Revenue ¹,2 Amount 27 13 9 49 Pct. 4% 8% 5% 5% This is a non-GAAP measure or non-GAAP ratio. See Slide 2 and Non-GAAP Appendix for further information on non-GAAP measures and ratios. Organic revenue growth/change, a non-GAAP ratio, is defined as a change on a period-over-period basis in revenues on a constant currency basis (if applicable) excluding the impact of acquisitions, divestitures and discontinuations. The impact for changes in foreign currency exchange rates is determined as the difference in the current period reported revenues at their current period currency exchange rates and the current period reported revenues revalued using the monthly average currency exchange rates during the comparable prior period. 41

View entire presentation